Keywords
MedicineCanakinumabThrombosisIntensive care medicineInternal medicineAnakinraDisease
Affiliated Institutions
Related Publications
Macrophage plasticity, polarization, and function in health and disease
Macrophages are heterogeneous and their phenotype and functions are regulated by the surrounding micro‐environment. Macrophages commonly exist in two distinct subsets: 1) Classi...
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
The inhalation of airborne pollutants, such as asbestos or silica, is linked to inflammation of the lung, fibrosis, and lung cancer. How the presence of pathogenic dust is recog...
Hypertension and the Pathogenesis of Atherosclerosis
Abstract Hypertension is a risk factor for the development of atherosclerosis, although the mechanisms have not been well elucidated. As the cellular and molecular mechanisms of...
Theophylline in the management of asthma: time for reappraisal?
Theophylline has been used for several decades in the treatment of asthma and remains the most widely prescribed anti-asthma drug worldwide, although the development of newer an...
Diabetes Prevention and Treatment Strategies
OBJECTIVE Effective interventions to prevent, delay, or remit diabetes are currently available. However, their impact on the prevalence of diabetes at the population level is un...
Publication Info
- Year
- 2011
- Type
- article
- Volume
- 162
- Issue
- 4
- Pages
- 597-605
- Citations
- 781
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
781
OpenAlex
Cite This
Paul M. Ridker,
Tom Thurén,
Andrew Zalewski
et al.
(2011).
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
American Heart Journal
, 162
(4)
, 597-605.
https://doi.org/10.1016/j.ahj.2011.06.012
Identifiers
- DOI
- 10.1016/j.ahj.2011.06.012